Albendazole
NDC Package 75929-184-92

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Albendazole is a medication used to treat certain tapeworm infections (such as neurocysticercosis and hydatid disease). Marketed by Pharma Packaging Solutions, Llc Dba Tjoapack Llc, this product is identified by NDC 75929-184 and is authorized under FDA application ANDA211117.

Identification & Billing

NDC Package Code
75929-184-92
Package Description
2 TABLET in 1 BOTTLE
Product Code
75929-184
11-Digit Billing Format
75929018492
RxNorm Crosswalk
RxCUI: 199672 - albendazole 200 MG Oral Tablet

Clinical Specifications

Proprietary Name
Albendazole
Dosage Form
-
Usage Information
This medication is used to treat certain tapeworm infections (such as neurocysticercosis and hydatid disease).

Regulatory & Marketing

Labeler Name
Pharma Packaging Solutions, Llc Dba Tjoapack Llc
FDA Application #
ANDA211117
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-19-2020
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 75929-184-92 identifies a specific commercial package of 2 tablet in 1 bottle of Albendazole, labeled by Pharma Packaging Solutions, Llc Dba Tjoapack Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pharma Packaging Solutions, Llc Dba Tjoapack Llc on August 19, 2020. The current certification is valid through December 31, 2024.

What are the primary indications for this medication?

This medication is used to treat certain tapeworm infections (such as neurocysticercosis and hydatid disease).

How is this Pharma Packaging Solutions, Llc Dba Tjoapack Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 75929018492. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
75929-184-92
11-Digit CMS (5-4-2)
75929-0184-92

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.